Skip to main content
. 2018 Jun 8;10:1461–1470. doi: 10.2147/CMAR.S161746

Table 2.

Summary of the malignant solid tumors

Malignant solid tumor Total patients, n (%)
Breast cancer 13 (31.0)
Renal cancer 7 (16.7)
Lung cancer 6 (14.3)
Colon carcinoma 3 (7.1)
Liver cancer 2 (4.8)
Endometrial adenosarcoma 2 (4.8)
Prostate cancer 1 (2.4)
Adrenal carcinoma 1 (2.4)
Endometrial carcinoma 1 (2.4)
Cutaneous basal cell carcinomas 1 (2.4)
Bladder carcinoma 1 (2.4)
Kaposi sarcoma 1 (2.4)
Ovarian endometrioid adenocarcinoma 1 (2.4)
Ovarian leiomyosarcoma 1 (2.4)
Melanoma 1 (2.4)